Ling Gao

Dr. Ling Gao

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2020 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JZJingjing Zheng
Jingjing Zheng
XZXimei Zhu
Ximei Zhu
YHYani He
Yani He
SHSiyu Hou
Siyu Hou
TLTing Liu
Ting Liu
LGLing Gao
Ling Gao

1 March 2020 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
GWGuojun Wu
Guojun Wu
WZWenhong Zhou
Wenhong Zhou
XPXiaohua Pan
Xiaohua Pan
ZSZhi-Gang Sun
Zhi-Gang Sun
YSYongjie Sun
Yongjie Sun
XTXingsong Tian
Xingsong Tian
Circular RNAs (circRNAs) are a class of noncoding RNAs that are broadly expressed in various biological cells and function in regulating gene expression. However, the molecular mechanisms that link circRNAs with progression of papillary thyroid carcinoma (PTC) are not well understood. In the present study, the function of circ_0006156 (circFNDC3B) was investigated in human PTC cells. First, we detected the expression of circFNDC3B in PTC tissues and PTC cell lines by RT-PCR. A luciferase reporter assay and AGO2-RNA immunoprecipitation (RIP) was used to confirm the relationship between circFNDC3B and microRNA (miR)-1178. PTC cells were stably transfected with small interfering RNA (siRNA) against circFNDC3B, and cell proliferation, migration, and invasion were detected to evaluate the effect of circFNDC3B in PTC, while tumorigenesis was assayed in nude mice. In this study, circFNDC3B was observed to be upregulated in PTC tissues and cell lines. Knockdown of circFNDC3B inhibited cell proliferation and promoted cell apoptosis in PTC cells. Bioinformatics analysis predicted that there is a circFNDC3B/miR-1178/Toll-like receptor 4 (TLR4) axis in PTC. The dual-luciferase reporter system validated the direct interaction of circFNDC3B, miR-1178, and TLR4. Furthermore, circFNDC3B facilitates PTC progression in vivo. Importantly, we demonstrated that circFNDC3B was upregulated in serum exosomes from PTC patients. In summary, our study demonstrated that circFNDC3B modulates PTC progression through the miR-1178/TLR4 pathway. Our findings indicated that circFNDC3B may serve as a promising therapeutic target for the treatment of PTC patients.

25 January 2022 in Pathology - Research and Practice
Verified
Journal Article
Closed access
KSKai Sun
Kai Sun
WRWenhao Ren
Wenhao Ren
SLShaoming Li
Shaoming Li
JZJingjing Zheng
Jingjing Zheng
YHYichuan Huang
Yichuan Huang
LGLing Gao
Ling Gao

15 November 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
KSKai Sun
Kai Sun
YZYuan Zhi
Yuan Zhi
WRWenhao Ren
Wenhao Ren
SLShaoming Li
Shaoming Li
XZXiaoqing Zhou
Xiaoqing Zhou
KZKeqian Zhi
Keqian Zhi
Ferroptosis is an iron-dependent regulated cell death, mainly manifested by the production of reactive oxygen species and accumulation of lipid peroxides. It is distinct from other forms of cell death with regard to morphology and biochemistry, particularly in disrupting mitochondrial function. Mitochondria are essential compartments where the organism generates energy and are closely associated with the fate of ferroptosis. Currently, researchers focus on the potential value of ferroptosis and mitochondria for overcoming drug sensitivity and assisting in cancer therapy. In this review, we summarize the main mechanisms of ferroptosis (the GPX4-realated pathway, FSP1-related pathway, and iron metabolism pathway) and the functions and regulating pathways of mitochondria (the TCA cycle, oxidative phosphorylation, mitochondrial regulation of iron ions, and mtDNA) in ferroptosis. We believe that exploring the role of mitochondria in ferroptosis will help us understand the potential regulatory mechanisms of ferroptosis in cancer and help us find new therapeutic targets.

1 November 2024 in Experimental Hematology & Oncology
Verified
Journal Article
Open access
PDF file
KSKai Sun
Kai Sun
YZYuan Zhi
Yuan Zhi
WRWenhao Ren
Wenhao Ren
SLShaoming Li
Shaoming Li
JZJingjing Zheng
Jingjing Zheng
KZKeqian Zhi
Keqian Zhi
Developing resistance to cancer treatments is a major challenge, often leading to disease recurrence and metastasis. Understanding the underlying mechanisms of therapeutic resistance is critical for developing effective strategies. O-GlcNAcylation, a post-translational modification that adds GlcNAc from the donor UDP-GlcNAc to serine and threonine residues of proteins, plays a crucial role in regulating protein function and cellular signaling, which are frequently dysregulated in cancer. Similarly, ubiquitination, which involves the attachment of ubiquitin to to proteins, is crucial for protein degradation, cell cycle control, and DNA repair. The interplay between O-GlcNAcylation and ubiquitination is associated with cancer progression and resistance to treatment. This review discusses recent discoveries regarding the roles of O-GlcNAcylation and ubiquitination in cancer resistance, their interactions, and potential mechanisms. It also explores how targeting these pathways may provide new opportunities to overcome cancer treatment resistance in cancer, offering fresh insights and directions for research and therapeutic development.

8 September 2019 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NZNanyang Zhang
Nanyang Zhang
LGLing Gao
Ling Gao
WRWenhao Ren
Wenhao Ren
SLShaoming Li
Shaoming Li
DZDemeng Zhang
Demeng Zhang
KZKeqian Zhi
Keqian Zhi